National Center of Neurology and Psychiatry, Japan
12
2
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.3%
1 terminated/withdrawn out of 12 trials
90.0%
+3.5% vs industry average
17%
2 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis
Role: lead
Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Role: lead
Phase II Clinical Trial of OCH-NCNP1
Role: lead
Exploratory Study of NS-089/NCNP-02 in DMD
Role: lead
Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research
Role: lead
Cognitive Rehabilitation During Transcranial Direct Current Stimulation
Role: lead
Exploratory Study of NS-065/NCNP-01 in DMD
Role: lead
Japan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP Study)
Role: lead
Happy Nurse Project: Lifestyle Interventions to Maintain Healthy Mental State in Hospital Nurses
Role: lead
Strategic Use of New Generation Antidepressants for Depression
Role: collaborator
RCT of Post-Suicide Attempt Case Management (ACTION-J)
Role: collaborator
A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J)
Role: collaborator
All 12 trials loaded